Gray matter (GM) magnetic resonance imaging (MRI) T2 hypointensity, a putative marker of iron deposition, commonly occurs in multiple sclerosis (MS). However, GM T2 hypointensity in benign MS (BMS) has not yet been characterized.
Objective
To determine the presence of deep GM T2 hypointensity in BMS, compare it to secondary progressive (SP) MS and assess its association with clinical and diffusion tensor (DT) MRI measures.
Methods
Thirty-five cognitively unimpaired BMS, 26 SPMS patients, and 25 healthy controls were analyzed for normalized T2-intensity in the basal ganglia and thalamus, global T2 hyperintense lesion volume, global atrophy, and white matter and GM DT metrics.
Results
BMS and SPMS patients showed deep GM T2 hypointensity compared with controls. T2 hypointensity was similar in both MS subgroups and moderately correlated (r = −0.45 to 0.42) with DT MRI metrics. GM T2 hypointensity in BMS showed a weak to moderate correlation (r = −0.44 to −0.35) with disability.
Conclusions
GM in BMS is not spared from structural change including iron deposition. However, while T2 hypointensity is related to global tissue disruption reflected in DT MRI, the expression of benign versus non-benign MS is likely related to other factors.
1 Hawkins SA Mc Donnell GV . Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry1999; 67: 148–152.
2.
2 Lublin FD Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46: 907–911.
3.
3 Pittock SJ Mc Clelland RL Mayr WT . Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol2004; 56: 303–306.
4.
4 Ramsaransing G Maurits N Zwanikken C De KJ . Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler2001; 7: 345–347.
5.
5 De Stefano N Battaglini M Stromillo ML . Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain2006; 129: 2008–2016.
6.
6 Ceccarelli A Rocca MA Pagani E . The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study. Neuroimage2008; 39: 1499–1509.
7.
7 Mesaros S Rovaris M Pagani E . An MRI voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol2008; 65: 1223–1230.
8.
8 Filippi M Campi A Mammi S . Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry1995; 58: 31–37.
9.
9 Filippi M Iannucci G Tortorella C . Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology1999; 52: 588–594.
10.
10 Filippi M Inglese M Rovaris M . Magnetization transfer imaging to monitor the evolution of MS: a one-year follow up study. Neurology2000; 55: 940–946.
11.
11 Falini A Calabrese G Filippi M . Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR Am J Neuroradiol1998; 19: 223–229.
12.
12 Strasser-Fuchs S Enzinger C Ropele S Wallner M Fazekas F . Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox? Mult Scler2008; 14: 205–211.
13.
13 Davie CA Silver NC Barker GJ . Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J Neurol Neurosurg Psychiatry1999; 67: 710–715.
14.
14 Droogan AG Clark CA Werring DJ Barker GJ McDonald WI Miller DH . Comparison of multiple sclerosis clinical subgroupsusing navigated spin echo diffusion-weighted imaging. Magn Reson Imaging1999; 17: 653–661.
15.
15 Horsfield MA Lai M Webb SL . Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med1996; 36: 393–400.
16.
16 Traboulsee A Dehmeshki J Peters KR . Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler2003; 9: 566–573.
17.
17 Rocca MA Valsasina P Ceccarelli A . Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp2007; 30: 276–290.
18.
18 Stankiewicz J Panter SS Neema M Arora A Batt CE Bakshi R . Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics2007; 4: 371–386.
19.
19 Bakshi R Shaikh ZA Janardhan V . MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport2000; 11: 15–21.
20.
20 Bakshi R Benedict RH Bermel RA . T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol2002; 59: 62–68.
21.
21 Tjoa CW Benedict RH Weinstock-Guttman B Fabiano AJ Bakshi R . MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci2005; 234: 17–24.
22.
22 Brass SD Benedict RH Weinstock-Guttman B Munschauer F Bakshi R . Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler2006; 12: 437–444.
23.
23 Ge Y Jensen JH Lu H . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol2007; 28: 1639–1644.
24.
24 Zhang Y Zabad RK Wei X Metz LM Hill MD Mitchell JR . Deep grey matter “blackT2” on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler2007; 13: 880–883.
25.
25 Hammond KE Metcalf M Carvajal L . Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol2008; 64: 707–713.
26.
26 Bermel RA Puli SR Rudick RA . Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol2005; 62: 1371–1376.
27.
27 Neema M Arora A Healy B . Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging2009; 19: 3–8.
28.
28 Polman CH Reingold SC Edan G . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
29.
29 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
30.
30 Gronwall DM . Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills1977; 44: 367–373.
31.
31 Bowie CR Harvey PD . Administration and interpretation of the trail making test. Nature Protoc2006; 1: 2277–2281.
32.
32 Spinnler H Tognoni G . Standardizzazione e taratura italiana di test neuropsicologici.Milan, Italy: Masson; 1981.
33.
33 Caffarra P Vezzadini G Dieci F Zonato F Vennari A . Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci2002; 22: 443–447.
34.
34 Basso A Capitani E Laiacona M . Raven’s coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol1987; 2: 189–194.
35.
35 De Renzi E Vignolo L . The Token Test: a sensitive test to detect receptive disturbance in aphasics. Brain1962; 85: 665–678.
36.
36 Pozzilli C Bastianello S Padovani A . Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex1991; 27: 441–445.
38 Camp S Stevenson VL Thompson AJ . Cognitive function in primary progressive and transitional progressive multiple sclerosis. A controlled study with MRI correlates. Brain1999; 122: 1341–1348.
39.
39 Rovaris M Filippi M Calori G . Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol1997; 244: 266–270.
40.
40 Smith SM Zhang Y Jenkinson M . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage2002; 17: 479–489.
41.
41 Rovaris M Gallo A Valsasina P . Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Neuroimage2005; 24: 1139–1146.
42.
42 Stokes M Davis CS Koch GG . Categorical data analysis using the SAS system. 2nd ed.; 2000 SAS Publishing, Cary, NC, USA.
43.
43 Prinster A Quarantelli M Orefice G . Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. NeuroImage2006; 29: 859–867.
44.
44 Xu X Wang Q Zhang M . Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage2008; 40: 35–42.
45.
45 Bakshi R Dmochowski J Shaikh ZA Jacobs L . Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci2001; 185: 19–26.
46.
46 Rovaris M Riccitelli G Judica E . Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology2008; 71: 1521–1526.
47.
47 Dehmeshki J Silver NC Leary SM Tofts PS Thompson AJ Miller DH . Magnetisation transfer ratio analysis of primary progressive and other multiple sclerosis subgroups. J Neurol Sci2001; 185: 11–17.
48.
48 Amato MP Portaccio E Stromillo ML . Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology2008; 71: 632–638.
49.
49 Geurts JJ Pouwels PJ Uitdehaag BM Polman CH Barkhof F Castelijns JA . Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology2005; 236: 254–260.
50.
50 Neema M Stankiewicz J Arora A . T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging2007; (Suppl. 1): 16S–21S (Review).
51.
51 Pfefferbaum A Adalsteinsson E Rohlfing T Sullivan EV . Diffusion tensor imaging of deep gray matter brain structures: Effects of age and iron concentration.Neurobiol Aging2008 [Epub ahead of print].
52.
52 Erb GL Osterbur DL LeVine SM . The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res Dev Brain Res1996; 93: 120–128.
53.
53 LeVine SM Macklin WB . Iron – enriched oligodendrocytes: a examination of their spatial distribution. J Neurosci Res1990; 26: 508–512.
54.
54 Quintana C Bellefqih S Laval JY . Study of the localization of iron, ferritin and hemosiderin, in Alzheimer disease hippocampus by analytical microscopy at subcellular level. J Struct Biol2006; 153: 42–54.
55.
55 Bartzokis G Tishler TA Lu PH . Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging2007; 28: 414–423.
56.
56 Fabiano AJ Sharma J Weinstock-Guttman B . Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging2003; 13: 307–314.
57.
57 Hasan KM Halphen C Kamali A Nelson FM Wolinsky JS Narayana PA . Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: Implications for understanding gray matter degeneration. J Magn Reson Imaging2009; 29: 70–77.
